Reconstructing hitting salespersons

Korea’s pharmaceutical sector is opening a fresh round of restructuring, with major drug firms poising to push employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.

Korean pharmaceutical companies are taking steps to reduce their workforces as they brace for lower earnings due to a policy to slash drug prices this year.

Part of efforts to c...